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dual antiplatelet therapy of clopidogrel and aspirin. The results
demonstrate that citrate anticoagulated plasma undergoes mark-
edly less platelet aggregation, which was significant at all concen-
trations of ADP tested. This is noteworthy because studies have
suggested that there is a relationship between the degree of platelet
inhibition and major adverse clinical events (5).
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Removal of Iodine Contrast From Coronary Sinus in Swine During Coronary Angiography
To the Editor: The use of contrast during coronary angiogra-
phy (CA) in patients with renal disease is associated with a
substantial risk of renal failure (30% to 50%). Previous studies
have shown that the amount of contrast used during CA
correlates with contrast-induced nephropathy (CIN) (1,2).
Despite preventive care, CIN occurs with high frequency and is
responsible for adverse outcomes (1,2). Most of the cardiac
veins drain into the coronary sinus (CS). Anatomically, it
should be possible to remove most of the contrast from the CS
during CA using a catheter that can occlude the CS and remove
blood distal to the occlusion. Commercially available CS
catheters such as Heartport (Redwood City, California) (3) are
safely used in the CS for cardioplegia or during biventricular
pacing. In this study, the Heartport catheter was used to remove
a mixture of blood and contrast from the CS during CA of five
pigs.
Five fasted swine were sedated with atropine (0.05 mg/kg,
intramuscular injection) and ketamine (20 mg/kg, intramuscular
injection) and anesthetized with isoflurane. The ventilator settings
were adjusted during the experiments to maintain normal partial
oxygen pressure (PO2) and partial carbon dioxide pressure (PCO2).
The left main coronary artery was accessed from the left carotid
artery using an 8-F multipurpose catheter. Standard techniques
were used with back flush of the contrast during CA under fluoros-
copy. Coronary angiography was performed after hand injection of 5
ml of a non-ionic iodinated contrast material (Omnipaque-350,
Amersham Health Inc., Princeton, New Jersey).
The CS was engaged by using a Heartport catheter (Ethicon
Inc., Cornelia, Georgia) (Fig. 1) via the external jugular vein
and 11-F sheath. Immediately after coronary injection, the
balloon at the tip of the catheter was inflated and CS blood was
collected for 10 s (50 cc). Contrast injection and removal were
repeated three times. The occlusion of CS did not affect CA
interpretation.
The amount of contrast in the collected blood from the CS was
quantified with high-performance liquid chromatography (samples
were analyzed by Galbraith Laboratories, Knoxville, Tennessee)
and a quantitative dual-energy technique developed in our labora-
tory. The University of California at Irvine Institutional Animal
Care Committee approved this study.
We used a quantitative dual energy technique (4) for iodine
mass determination. All images were acquired using a conven-
Figure 1. Percent platelet aggregation in patients on clopidogrel using different concentrations of adenosine diphosphate (ADP) and either citrate (open
bars) or PPACK (solid bars) as anticoagulant. *p  0.05.
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tional X-ray tube (Dynamax 79-45/120, Machlett Laboratories,
Stamford, Connecticut), a constant potential X-ray generator
(Optimus M200, Philips Medical Systems, Shelton, Connect-
icut), and a PaxScan 4030A flat panel detector (Varian Medical
Systems, Salt Lake City, Utah). The syringes used to collect the
blood samples were imaged over a step phantom with 7.50-cm,
9.25-cm, 11.00-cm, and 13.00-cm steps and an air gap of 10 cm
between the phantom and detector. Low-energy images were
acquired at 60 kVp and 6.0 mAs. High-energy images were
acquired at 120 kVp and 5.0 mAs with an added 0.8-mm thick 925
sterling silver filter. Low- and high-energy images were corrected
for scatter-veiling glare (5). The images were then logarithmically
subtracted to form tissue-suppressed dual-energy images. An
integrated iodine mass signal was obtained by summing all the
background subtracted pixel values inside the region of interest for
all the images. Control syringes containing blood drawn without
contrast injection were used to subtract background blood signal
from samples containing injected contrast material. The fraction of
iodine recovered was determined from the ratio of collected iodine
mass as quantified by dual energy logarithmic subtraction per
injected iodine mass.
All pigs tolerated the procedure without complication. The
removal of blood caused no significant hemodynamic compro-
mise. Complete occlusion of the CS was confirmed under
fluoroscopy by injecting contrast material distal to the inflated
balloon. The analysis of the collected blood samples revealed
that 50.6  12% of the injected contrast material was removed
from the CS.
Patients with underlying renal disease undergoing a CA are
at high risk for CIN. It is well known that the amount of
contrast material used in coronary interventions correlates with
CIN (1,2). The major veins of the heart drain into the CS. By
using an occlusive balloon-tipped catheter in the ostium of the
CS, we removed approximately 50% of the injected contrast in
a swine model without complication. A pig’s heart closely
resembles a human’s heart except for the presence of a large left
azygos vein that empties into the CS (6,7). This anatomical
shunt from the CS to the systemic circulation in pigs is most
likely responsible for the lower-than-expected contrast removal
in this study.
In humans, the connections to the systemic vein are minimal via
ventricular thebesian veins (8). Therefore, it should be possible to
remove most of the contrast from the CS before it enters the
systemic circulation in humans, which may protect kidneys from
CIN. However, anatomical variation of venous drainage of the
heart is one of the limitations of this study for human use. The
amount of blood lost during removal of contrast from the CS
should be lower than 300 cc for conventional CA, which should be
well tolerated. Access to the CS in humans can be obtained via the
jugular vein without difficulty using currently available CS cathe-
ters with the addition of 30 min time to the procedure. The
ability of our method to reduce CIN needs to be investigated by a
randomized trial.
Using swine, despite an anatomical shunt from the CS to the
systemic circulation via the azygos vein, we removed an average of
50.6  12% of the injected contrast from the CS during CA. This
study reports the first method for contrast removal during CA.
Because the anatomical shunt from the CS to the systemic
circulation is very small in humans, a higher yield of contrast
removal from the CS can be expected for humans with the
potential to reduce CIN.
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Figure 1. Simultaneous contrast injection into the left main coronary and occlusion of the coronary sinus showing contrast trapped in the coronary sinus
before entering systemic circulation for removal (30° right anterior oblique view).
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Letters to the Editor
Effects of N-3 Fatty Acids
on Postoperative Atrial Fibrillation
Following Coronary Artery Bypass Surgery
We read with considerable interest the recent contribution by Calò
et al. (1) about the reduced incidence of postoperative atrial
fibrillation (AF) after administration of n-3 polyunsaturated fatty
acids (PUFAs) in patients undergoing coronary artery bypass
surgery (CABG). Even though the investigators discuss the
potential role of inflammation in this setting we consider that some
important issues merit further clarification.
First, 19 of the studied patients were subjected to off-pump
surgery, a procedure considered to be associated with a lesser
oxidative and inflammatory response (2). Bearing in mind the
hypothesis that postoperative AF may be reduced by off-pump
CABG (3), it would be meaningful to examine whether there was
a difference in the incidence of postoperative AF in this subset of
patients.
In addition, it has been observed that the peak incidence of AF
on the second or third postoperative day coincides with the peak of
inflammatory markers such as C-reactive protein (CRP) and
complement-CRP complexes (4). Recently, Abdelhadi et al. (5)
confirmed this association, demonstrating a more pronounced and
prolonged increase in white blood cell counts of patients who
developed postoperative AF. Thus, to validate the anti-inflammatory
effects of PUFAs someone could investigate the variation of simple
inflammatory indexes in the postoperative period. If Calò et al. have
some available data on this issue it would be of interest to perform
comparisons between the two groups.
Of note, more than one-half the total study population was
taking statins perioperatively (1). Even though there were no
differences regarding statin administration between the studied
groups, the investigators could mention some data on potential
differences in the incidence of postoperative AF within each group.
Statins may exert beneficial pleiotropic effects on atrial remodeling,
reducing the burden of the arrhythmia. It has also been indicated
that statin therapy reduces the incidence of arrhythmias after
CABG, although no specific data on AF was reported (6).
Recently, Auer et al. (7) demonstrated a reduced incidence of AF
after cardiac operation in patients receiving statins, but 44.7% of
these had been subjected to valve surgery.
Accumulating evidence suggests that inflammation augments
oxidative stress and vice versa, whereas oxidative stress seems to
play an important role in atrial remodeling (2,8). Specifically, it has
been shown that oral vitamin C administration significantly
reduces the incidence of postoperative AF in CABG patients (8).
Taking into account that PUFAs can attenuate oxidative stress in
humans (9), it is reasonable to assume that their antioxidant action
may contribute to their favorable effect on postoperative AF.
Finally, we concur with the view of Calò et al. that adminis-
tration of PUFAs merits further evaluation in other forms of AF,
but, as suggested by a recent study that reported no association
between PUFA consumption from fish and the risk of AF (10),
careful selection of the studied population should be performed.
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